|
US2020383372A1
|
|
Nicotine pouch composition and pouch comprising such
|
|
US2020078349A1
|
|
Oral delivery vehicle containing nicotine
|
|
US2021106516A1
|
|
Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
|
|
US2021106521A1
|
|
Compressed nicotine lozenge
|
|
CN112118831A
|
|
Tabletted chewing gum suitable for active pharmaceutical ingredients
|
|
EP3720497A1
|
|
High nicotine concentration
|
|
US2019175581A1
|
|
Nicotine tablet
|
|
US2020397691A1
|
|
Nicotine mouth spray
|
|
CN111432840A
|
|
Solid oral nicotine formulation
|
|
EP3720498A1
|
|
High nicotine absorption
|
|
US2019255035A1
|
|
Nicotine Pouch
|
|
US2019358159A1
|
|
Tableted chewing gum suitable for active pharmaceutical ingredients
|
|
US2019350857A1
|
|
Oral tablet for taste masking of active ingredients
|
|
US2019350848A1
|
|
Oral tablet for delivery of active ingredients to the throat
|
|
US2019350862A1
|
|
Oral tablet suitable for fast release of active pharmaceutical ingredients
|
|
US2019350858A1
|
|
Oral tablet for delivery of active ingredients to the gastrointestinal tract
|
|
US2019350860A1
|
|
Oral Tablet Suitable For Active Pharmaceutical Ingredients
|
|
US2019350847A1
|
|
Disintegrating oral tablet suitable for active pharmaceutical ingredients
|
|
US2019350859A1
|
|
Oral Tablet For Induced Saliva Generation
|
|
US2019350861A1
|
|
Tablet Dosage Form For Buccal Absorption Of Active Ingredients
|
